UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI

Figure 4

Kaplan–Meier survival curves for (a) progress-free survival and (b) overall survival stratified by irinotecan escalation or no escalation.

(a)

(b)